FREQUENCY OF HUMAN CYP2D6 MUTANT ALLELES IN A NORMAL CHINESE POPULATION

被引：26

作者：

LEE, EJD ^{[1
]}

JEYASEELAN, K ^{[1
]}

机构：

[1] NATL UNIV SINGAPORE,DEPT BIOCHEM,SINGAPORE 0511,SINGAPORE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 37卷 / 06期

关键词：

GENETIC POLYMORPHISM; CYP2D6; CHINESE CYTOCHROME P450;

D O I：

10.1111/j.1365-2125.1994.tb04311.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Substantial differences in the pharmacogenetics of debrisoquine hydroxylation exist between Caucasians and Chinese populations. Among Chinese, not only is the frequency of the poor metabolizer phenotype low, the contribution of the 29B mutation in the CYP2D6 gene is insignificant. By contrast the frequency of D6-J is very common (similar to 0.6) and is clearly related to the activity of debrisoquine hydroxylase. Its presence however, does not predict the poor metabolizer phenotype. The D6-C mutation was also not detectable in our population.

引用

页码：605 / 607

页数：3

共 50 条

[31] Novel CYP2D6 alleles in African Americans.
Gaedigk, A
Leeder, JS
Bradford, LD
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P94 - P94
[32] CYP2D6 genotyping in Asians: An algorithm based upon determination of CYP2D6*4,*5, and*10 alleles
Kwong, EH
Levine, M
Montgomery, CJ
Chang, TKH
DRUG METABOLISM REVIEWS, 2004, 36 : 116 - 116
[33] Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population
Garcia-Barceló, M
Chow, LY
Chiu, HFK
Wing, YK
Lee, DTS
Lam, KL
Waye, MMY
CLINICAL CHEMISTRY, 2000, 46 (01) : 18 - 23
[34] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
Dalton, Rachel
Lee, Seung-been
Claw, Katrina G.
Prasad, Bhagwat
Phillips, Brian R.
Shen, Danny D.
Wong, Lai Hong
Fade, Mitch
McDonald, Matthew G.
Dunham, Maitreya J.
Fowler, Douglas M.
Rettie, Allan E.
Schuetz, Erin
Thornton, Timothy A.
Nickerson, Deborah A.
Gaedigk, Andrea
Thummel, Kenneth E.
Woodahl, Erica L.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
[35] The association between CYP2D6 genetic polymorphism and schizophrenia in a Chinese population
Zhou, Jian
Wang Yajie
Wang, Gang
Chen Xueyan
Lv, Hong
Kang Xixiong
PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, : 453 - 455
[36] Estimating the In Vivo Function of CYP2D6 Alleles through Population Pharmacokinetic Modeling of Brexpiprazole
Frederiksen, Trine
Areberg, Johan
Raoufinia, Arash
Schmidt, Ellen
Stage, Tore Bjerregaard
Brosen, Kim
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (02) : 360 - 369
[37] High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population
Pietarinen, Paavo
Tornio, Aleksi
Niemi, Mikko
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (03) : 291 - 296
[38] A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: Association with diminished debrisoquine hydroxylase activity
Masimirembwa, C
Persson, I
Bertilsson, L
Hasler, J
IngelmanSundberg, M
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (06) : 713 - 719
[39] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
Nahid, N.
Kanumuri, S.
Sharma, A.
Wang, D.
Johnson, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
[40] Tardive dyskinesia and CYP2D6 polymorphism in Chinese
Chong, SA
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 586 - 586

← 1 2 3 4 5 →